Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors.

Kandasamy M. et al, (2023), Elife, 12

Recombinant single-cycle influenza virus as a new tool to augment antitumour immunity with immune checkpoint inhibitors

Kandasamy M. et al, (2021)

Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1157-165 tumor-specific peptide.

Shenderov E. et al, (2021), J immunother cancer, 9

Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.

Kandasamy M. et al, (2020), J virol, 94

Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells.

Bedard M. et al, (2019), Proc natl acad sci u s a, 116, 23671 - 23681

Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication.

Han J. et al, (2018), Cell rep, 23, 596 - 607

Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis.

Yildiz S. et al, (2018), Microbiome, 6

Igβ ubiquitination activates PI3K signals required for endosomal sorting.

Veselits M. et al, (2017), J exp med, 214, 3775 - 3790

Transient ablation of alveolar macrophages leads to massive pathology of influenza infection without affecting cellular adaptive immunity.

Purnama C. et al, (2014), Eur j immunol, 44, 2003 - 2012

Include forthcoming?